Published in Kidney Int on August 08, 2007
Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol (2008) 3.10
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol (2010) 3.07
A rapid urine test for early detection of kidney injury. Kidney Int (2009) 2.50
Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol Appl Pharmacol (2009) 1.81
Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int (2010) 1.67
Biomarkers of nephrotoxic acute kidney injury. Toxicology (2008) 1.55
Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol (2009) 1.41
Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr Nephrol (2010) 1.25
Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci (2009) 1.18
Mechanisms of cadmium-induced proximal tubule injury: new insights with implications for biomonitoring and therapeutic interventions. J Pharmacol Exp Ther (2012) 0.99
Marking renal injury: can we move beyond serum creatinine? Transl Res (2012) 0.98
Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J (2011) 0.98
Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol Appl Pharmacol (2009) 0.97
Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci (2010) 0.93
Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity. Biochem Pharmacol (2013) 0.90
Determination of Clara cell protein urinary elimination as a marker of tubular dysfunction. Pediatr Nephrol (2009) 0.89
The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study. Environ Health (2011) 0.88
Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity. Toxicol Appl Pharmacol (2009) 0.87
Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development. Br J Clin Pharmacol (2014) 0.87
Aging and the disposition and toxicity of mercury in rats. Exp Gerontol (2014) 0.85
Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology. Biomed Res Int (2014) 0.81
Novel Hg2+-induced nephropathy in rats and mice lacking Mrp2: evidence of axial heterogeneity in the handling of Hg2+ along the proximal tubule. Toxicol Sci (2014) 0.81
Evaluation of cystatin C as an early biomarker of cadmium nephrotoxicity in the rat. Biometals (2015) 0.81
Effects of Maternal Exposure to Cadmium Oxide Nanoparticles During Pregnancy on Maternal and Offspring Kidney Injury Markers Using a Murine Model. J Toxicol Environ Health A (2015) 0.79
New biomarkers for the quick detection of acute kidney injury. ISRN Nephrol (2012) 0.78
Environmental exposure to arsenic and chromium in children is associated with kidney injury molecule-1. Environ Res (2016) 0.77
Renoprotective mechanisms of soy protein intake in the obese Zucker rat. Am J Physiol Renal Physiol (2008) 0.77
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats. Antimicrob Agents Chemother (2016) 0.76
Biomarkers in Acute Kidney Injury. Biomark Insights (2008) 0.75
Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells. Am J Physiol Renal Physiol (2016) 0.75
Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice. Biomed Res Int (2015) 0.75
Impaired endocytosis in proximal tubule from subchronic exposure to cadmium involves angiotensin II type 1 and cubilin receptors. BMC Nephrol (2013) 0.75
Cadmium Level, Glycemic Control, and Indices of Renal Function in Treated Type II Diabetics: Implications for Polluted Environments. Front Public Health (2016) 0.75
Effects of sub-chronic Cd exposure on levels of copper, selenium, zinc, iron and other essential metals in rat renal cortex. Toxicol Rep (2016) 0.75
24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury. Antimicrob Agents Chemother (2017) 0.75
Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int (2002) 8.03
Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand J Work Environ Health (1998) 4.65
Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol (2005) 3.94
Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol (2003) 3.61
Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol (1999) 2.95
Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem (2002) 2.36
Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect (2005) 2.29
The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol (1998) 2.05
Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol (2006) 1.85
Identification of putative gene based markers of renal toxicity. Environ Health Perspect (2004) 1.85
Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci U S A (1974) 1.80
Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care (2004) 1.75
Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem (2003) 1.63
Cadmium overload and toxicity. Nephrol Dial Transplant (2002) 1.57
Cadmium exposure and end-stage renal disease. Am J Kidney Dis (2001) 1.55
Cadmium-metallothionein-induced nephropathy. Toxicol Appl Pharmacol (1976) 1.48
Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol (2006) 1.47
Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci (2000) 1.45
Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals (2004) 1.44
Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem (1994) 1.41
Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol (2006) 1.36
Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit Rev Toxicol (1992) 1.25
Cadmium and the kidney. Environ Health Perspect (1984) 1.20
Clara cell proteins. Ann N Y Acad Sci (2000) 1.19
Carcinogenic, teratogenic and mutagenic effects of cadmium. Mutat Res (1981) 1.17
Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants. Toxicol Appl Pharmacol (1999) 1.16
Cadmium alters the localization of N-cadherin, E-cadherin, and beta-catenin in the proximal tubule epithelium. Toxicol Appl Pharmacol (2003) 1.10
Zinc protects renal function during cadmium intoxication in the rat. Am J Physiol Renal Physiol (2005) 1.09
General aspects of cadmium: transport, uptake and metabolism by the kidney. Environ Health Perspect (1984) 1.09
Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity. Drug Metab Rev (1997) 1.07
Characterization of cadmium proteinuria in man and rat. Environ Health Perspect (1984) 1.02
Non-metallothionein-bound cadmium in the pathogenesis of cadmium nephrotoxicity in the rat. Toxicol Appl Pharmacol (1989) 0.98
Evidence that E-cadherin may be a target for cadmium toxicity in epithelial cells. Toxicol Appl Pharmacol (2000) 0.97
Cadmium, metallothionein and renal tubular toxicity. IARC Sci Publ (1992) 0.97
Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity. Toxicol Appl Pharmacol (1985) 0.97
Effects of cadmium on E-cadherin and VE-cadherin in mouse lung. Life Sci (2003) 0.94
Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan. Environ Res (2006) 0.93
Cadmium in human population. Experientia (1984) 0.93
Antigenic, molecular and functional heterogeneity of Clara cell secretory proteins in the rat. Biochim Biophys Acta (1985) 0.92
Metallothionein in plasma and urine of cadmium-exposed rats determined by a single-antibody radioimmunoassay. Fundam Appl Toxicol (1983) 0.92
Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China. Toxicol Appl Pharmacol (2006) 0.91
Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity. Ren Fail (1999) 0.91
New approaches for detecting thresholds of human nephrotoxicity using cadmium as an example. Environ Health Perspect (1998) 0.90
A novel method for the evaluation of proximal tubule epithelial cellular necrosis in the intact rat kidney using ethidium homodimer. BMC Physiol (2007) 0.88
Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex. Toxicol Sci (1998) 0.88
Urinary protein 1 or Clara cell protein: a new sensitive marker of proximal tubular dysfunction. Kidney Int Suppl (1994) 0.88
Cadmium: biological effects and occurrence in the enviroment. Annu Rev Pharmacol (1975) 0.87
CC16 as a marker of lung epithelial hyperpermeability in an acute model of rats exposed to mainstream cigarette smoke. Toxicol Lett (2005) 0.87
Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J (1998) 0.87
Urinary metallothionein and tissue metal levels of rats injected with cadmium, mercury, lead, copper or zinc. Toxicology (1983) 0.86
Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding. J Pharmacol Exp Ther (1984) 0.86
Urinary excretion of beta2-microglobulin and other proteins in workers exposed to cadmium, lead or mercury. Pathol Biol (Paris) (1978) 0.86
Cadmium metabolism and toxicity in rats after long-term subcutaneous administration. J Toxicol Environ Health (1980) 0.85
Environmental pollutants and diseases. A cell biological approach using chronic cadmium exposure in the animal model as a paradigm case. Toxicology (1991) 0.85
Increased serum and urinary concentrations of lung clara cell protein in rats acutely exposed to ozone. Toxicol Appl Pharmacol (1999) 0.84
Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicol Appl Pharmacol (2004) 0.84
Biomonitoring of early effects on the kidney or the lung. Sci Total Environ (1997) 0.84
Some observations on the kinetics of the Jaffé reaction for creatinine. Clin Chem (1977) 0.84
Anthropometric, environmental, and dietary predictors of elevated blood cadmium levels in Ukrainian children: Ukraine ELSPAC group. Environ Res (2006) 0.84
Excretion of urinary cadmium, copper, and zinc in cadmium-exposed and nonexposed subjects, with special reference to urinary excretion of beta2-microglobulin and metallothionein. Biol Trace Elem Res (2005) 0.83
Low-molecular-weight proteins as markers of organ toxicity with special reference to Clara cell protein. Toxicol Lett (1995) 0.83
Biological monitoring for occupational cadmium exposure: the urinary metallothionein. Toxicology (1990) 0.82
Characterization of the beta 2-microglobulin endocytic pathway in rat proximal tubule cells. Am J Physiol (1994) 0.81
Serum clara-cell protein and beta2-microglobulin as early markers of occupational exposure to nitric oxides. Inhal Toxicol (2005) 0.80
Significance of increase in urinary metallothionein of rats repeatedly exposed to cadmium. Toxicology (1986) 0.80
Intracellular metabolism and effects of circulating cadmium-metallothionein in the kidney. Environ Health Perspect (1984) 0.79
Modulation of metal toxicity by metallothionein. Biol Trace Elem Res (1990) 0.79
Urinary metallothionein as an indicator of cadmium body burden and of cadmium-induced nephrotoxicity. Environ Health Perspect (1984) 0.79
Biological indicators of cadmium exposure and toxicity. Experientia Suppl (1986) 0.78
Application of path analysis to urinary findings of cadmium-induced renal dysfunction. J Environ Sci Health A Tox Hazard Subst Environ Eng (2001) 0.78
beta2-Microglobulin: present status. Prog Clin Biol Res (1976) 0.78
Effect of calmodulin-inhibitors and verapamil on the nephrotoxicity of cadmium in rat. Toxicol Lett (1998) 0.77
beta 2-Microglobulin: methods and clinical applications. CRC Crit Rev Clin Lab Sci (1979) 0.77
Purification and cellular localization of beta2-microglobulin in the testis. Life Sci (1997) 0.77
Measurement of cadmium-induced metallothionein in urine by ELISA and prevention of overestimation due to polymerization. J Anal Toxicol (1999) 0.77
Are peripheral blood lymphocytes the source of elevated B-2-microglobulin in renal transplant recipients? Transplant Proc (1989) 0.76
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11
Acute renal failure. N Engl J Med (1996) 8.83
fw2.2: a quantitative trait locus key to the evolution of tomato fruit size. Science (2000) 7.91
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med (1999) 7.90
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell (1997) 7.27
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (2001) 6.36
Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science (1999) 6.02
Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem (1998) 5.99
Digital tomosynthesis in breast imaging. Radiology (1997) 5.82
Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A (1997) 5.76
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol (2000) 5.38
Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (1995) 5.25
High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod (1993) 5.06
Comparing sequenced segments of the tomato and Arabidopsis genomes: large-scale duplication followed by selective gene loss creates a network of synteny. Proc Natl Acad Sci U S A (2000) 4.90
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 4.82
Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med (1991) 4.72
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol (2001) 4.38
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis (2002) 4.35
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (1996) 3.99
Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A (1996) 3.83
Ultralong single-wall carbon nanotubes. Nat Mater (2004) 3.83
Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis (1999) 3.77
Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest (1996) 3.73
Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature (1993) 3.67
A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia (2007) 3.45
Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int (2016) 3.30
Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care (2001) 3.27
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (1989) 3.27
Genetic analysis of salt tolerance in arabidopsis. Evidence for a critical role of potassium nutrition. Plant Cell (1998) 3.25
Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int (2007) 3.23
The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23
The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17
Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med (1991) 3.06
Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care (1997) 3.03
Blood contacts during surgical procedures. JAMA (1991) 3.03
Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem (1996) 3.01
Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem (2000) 3.01
Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A (1992) 3.01
National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control (1991) 3.00
Acupuncture modulates the limbic system and subcortical gray structures of the human brain: evidence from fMRI studies in normal subjects. Hum Brain Mapp (2000) 2.98
Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol (1999) 2.95
Genetic architecture of a morphological shape difference between two Drosophila species. Genetics (2000) 2.92
New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92
SOS3 function in plant salt tolerance requires N-myristoylation and calcium binding. Plant Cell (2000) 2.91
Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol (1995) 2.88
Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. Nat Genet (1998) 2.87
Regular source of ambulatory care and access to health services. Am J Public Health (1991) 2.86
Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int (2007) 2.86
Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev (2001) 2.84
Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J (1998) 2.83
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene (2012) 2.82
Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75
Toxicity of ALS-linked SOD1 mutants. Science (2000) 2.69
Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant (2014) 2.67
Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation (2001) 2.56
A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci U S A (1996) 2.54
Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol (1993) 2.54
Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A (1997) 2.51
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
The Krüppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci U S A (1994) 2.46
Intracytoplasmic single sperm injection of 1-day-old unfertilized human oocytes. Hum Reprod (1993) 2.46
Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem (1995) 2.41
Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol (1997) 2.41
The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem (1998) 2.39
Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol (1994) 2.36
Structure of a rhamnolipid from Pseudomonas aeruginosa. Arch Biochem Biophys (1965) 2.35
Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis (1993) 2.34
Epidemiological link between exposure to poultry and all influenza A(H7N9) confirmed cases in Huzhou city, China, March to May 2013. Euro Surveill (2013) 2.34
Inner ear defects induced by null mutation of the isk gene. Neuron (1996) 2.34
Gate-voltage control of chemical potential and weak antilocalization in Bi₂Se₃. Phys Rev Lett (2010) 2.32
Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A (1994) 2.26
Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics (1999) 2.25
A comparative linkage map of oilseed rape and its use for QTL analysis of seed oil and erucic acid content. Theor Appl Genet (2006) 2.21
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20
The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate. J Bacteriol (1992) 2.20
Classification and 3D averaging with missing wedge correction in biological electron tomography. J Struct Biol (2008) 2.19
Formation of a gated channel by a ligand-specific transport protein in the bacterial outer membrane. Science (1992) 2.19
Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines. AIDS Res Hum Retroviruses (1990) 2.18
Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18
An introgression analysis of quantitative trait loci that contribute to a morphological difference between Drosophila simulans and D. mauritiana. Genetics (1997) 2.17
Lung hyperpermeability and asthma prevalence in schoolchildren: unexpected associations with the attendance at indoor chlorinated swimming pools. Occup Environ Med (2003) 2.16
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci U S A (1999) 2.16
The DNA replication protein PriA and the recombination protein RecG bind D-loops. J Mol Biol (1997) 2.13
C. elegans nuclear envelope proteins emerin, MAN1, lamin, and nucleoporins reveal unique timing of nuclear envelope breakdown during mitosis. Mol Biol Cell (2000) 2.11
Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis (2001) 2.10
Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res (1997) 2.05
Evaluating the care of general medicine inpatients: how good is implicit review? Ann Intern Med (1993) 2.03
Automatic prediction of protein function. Cell Mol Life Sci (2003) 2.03
Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. Hum Reprod (1993) 2.02
Correlation between growth inhibition and the binding of various penicillins and cephalosporins to Staphylococcus aureus. J Bacteriol (1969) 2.01
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene (2009) 2.01
Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell (2001) 2.00
Neonatal blood: a source of haematopoietic stem cells for transplantation? Lancet (1998) 1.99
Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci U S A (2001) 1.98
The RING finger/B-box factor TAM-1 and a retinoblastoma-like protein LIN-35 modulate context-dependent gene silencing in Caenorhabditis elegans. Genes Dev (1999) 1.97